Skip to main content
SpringerLink
Log in

Fungal Infections of the Central Nervous System

  • Chapter
  • First Online:
CNS Infections

Abstract

Fungal infections of the central nervous system (CNS) represent a diagnostic and therapeutic challenge and are associated with high morbidity and mortality. The incidence of invasive fungal infections has increased over time with the rise of at-risk populations including organ transplants, chemotherapy, and human immunodeficiency virus infections among other conditions. Respiratory tract or sinuses are usually the most common port of entry, and then fungi spread hematogenously or by contiguity to the CNS. Infection may also occur after neurosurgical procedures and catheters, trauma, skin burns and penetrating wounds, and near drowning. CNS fungal infections may present as an acute or chronic meningitis, brain abscess, occupying space lesions, hydrocephalus, stroke, vasculitis, and arachnoiditis. In this chapter, the most common etiologies of CNS infections will be reviewed, including Cryptococcus, Candida, Aspergillus, Mucor, endemic dimorphic fungi (Histoplasma, Coccidioides, Blastomyces), and other more rare pathogens including Exserohilum rostratum and Scedosporium spp. Management include the use of amphotericin B, flucytosine, triazoles (voriconazole, posaconazole, fluconazole, itraconazole), and surgery for large brain mass. Long-term azole therapy may be needed for chronic infections to avoid recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pilmis B, Puel A, Lortholary O, Lanternier F. New clinical phenotypes of fungal infections in special hosts. Clin Microbiol Infect. 2016;22:681–7.

    Article  CAS  PubMed  Google Scholar 

  2. Murthy JMK, Sundaram C. Fungal infections of the central nervous system. Handb Clin Neurol. 2014;121:1383–401.

    Article  CAS  PubMed  Google Scholar 

  3. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull. 2004;72:99–118.

    Article  PubMed  Google Scholar 

  4. La Hoz RM, Pappas PG. Cryptococcal infections: changing epidemiology and implications for therapy. Drugs. 2013;73:495–504.

    Article  PubMed  CAS  Google Scholar 

  5. Sethi PK, Khanna L, Batra A, Anand I, Sethi NK, Torgovnick J, et al. Central nervous system fungal infections: observations from a large tertiary hospital in northern India. Clin Neurol Neurosurg. 2012;114:1232–7.

    Article  PubMed  Google Scholar 

  6. Al-Abdely HM, Alothman AF, Salman JA, Al-Musawi T, Almaslamani M, Butt AA, et al. Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations. J Infect Public Health. 2014;7:20–31.

    Article  PubMed  Google Scholar 

  7. Panackal AA, Williamson PR. Fungal infections of the central nervous system. Continuum (Minneap Minn). 2015;21:1662–78.

    Google Scholar 

  8. McCarthy MW, Walsh TJ. Molecular diagnosis of invasive mycoses of the central nervous system. Expert Rev Mol Diagn. 2017;17:129–39.

    Article  CAS  PubMed  Google Scholar 

  9. Gavito-Higuera J, Mullins CB, Ramos-Duran L, Olivas Chacon CI, Hakim N, Palacios E. Fungal infections of the central nervous system: a pictorial review. J Clin Imaging Sci. 2016;6:24.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O. on behalf of the ESCMID EFISG study group and ECM. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect. 2014;20(Suppl. 3):76–9.

    Article  CAS  PubMed  Google Scholar 

  11. Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, et al. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2016;13:13–24. https://doi.org/10.1038/nrneuol.2016.167.

    Article  PubMed  CAS  Google Scholar 

  12. Harris JR, Lockhart SR, Debess E, Marsden-Haug N, Goldoft M, Wohrle R, et al. Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011;53:1188–95.

    Article  CAS  PubMed  Google Scholar 

  13. Henao-Martínez AF, Beckham JD. Cryptococcosis in solid organ transplant recipients. Curr Opin Infect Dis. 2015;28:300–7.

    Article  PubMed  Google Scholar 

  14. Schmalzle SA, Buchwald UK, Gilliam BL, Riedel DJ. Cryptococcus neoformans infection in malignancy. Mycoses. 2016;59:542–52.

    Article  PubMed  Google Scholar 

  15. Hadid H, Nona P, Usman M, Paje D. Cryptococcal eosinophilic meningitis in a patient with sarcoidosis. BMJ Case Rep. 2015;2015. pii:bcr2015212765. https://doi.org/10.1136/bcr-2015-212765.

  16. Jiang S, Lei TC, Xu SZ. Successful treatment of cryptococcal meningitis with amphotericin B in a patient with systemic lupus erythematosus. West Indian Med J. 2015;65:222–5. https://doi.org/10.7727/wimj.2014.352.

    CAS  PubMed  Google Scholar 

  17. Saijo T, Chen J, Chen SC, Rosen LB, Yi J, Sorrell TC, et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. MBio. 2014;5:e00912–4.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  18. Ward MD, Jones DE, Goldman MD. Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis. Mult Scler Relat Disord. 2016;9:47–9.

    Article  PubMed  Google Scholar 

  19. Achtnichts L, Obreja O, Conen A, Fux CA, Nedeltchev K. Cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimod. JAMA Neurol. 2015;72:1203–5.

    Article  PubMed  Google Scholar 

  20. Huang D. Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod. Neurology. 2015;85:1001–3.

    Article  PubMed  Google Scholar 

  21. Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know. Fungal Genet Biol. 2015;78:49–54.

    Article  PubMed  Google Scholar 

  22. Chitty JL, Tatzenko TL, Williams SJ, Koh YQ, Corfield EC, Butler MS, et al. GMP synthase is required for virulence factor production and infection by Cryptococcus neoformans. J Biol Chem. 2017;292:3049–59.

    Article  CAS  PubMed  Google Scholar 

  23. Maziarz EK, Perfect JR. Cryptococcosis. Infect Dis Clin N Am. 2016;30:179–206.

    Article  Google Scholar 

  24. Merkler AE, Gaines N, Baradaran H, Schuetz AN, Lavi E, Simpson SA, et al. Direct invasion of the optic nerves, chiasm, and tracts by Cryptococcus neoformans in an immunocompetent host. Neurohospitalist. 2015;5:217–22.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Lomes NR, Melhem MS, Szeszs MW, Martins Mdos A, Buccheri R. Cryptococcosis in non-HIV/non-transplant patients: A Brazilian case series. Med Mycol. 2016;54:669–76.

    Article  PubMed  Google Scholar 

  26. Henao-Martínez AF, Gross L, Mcnair B, McCollister B, DeSanto K, Montoya JG, et al. Risk factors for cryptococcal meningitis: a single United States center experience. Mycopathologia. 2016;181:807–14.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Ulett KB, Cockburn JW, Jeffree R, Woods ML. Cerebral cryptococcoma mimicking glioblastoma. BMJ Case Rep. 2017;2017. pii:bcr2016218824.

    Google Scholar 

  28. Cachia D, Singh C, Tetzlaff MT, Penas-Prado M. Middle cerebral artery territory infarct due to Cryptococcus infections: an uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopathol. 2015;43:632–4.

    Article  PubMed  Google Scholar 

  29. Rosario M, Song SX, McCullough LD. An unusual case of stroke. Neurologist. 2012;18:229–32.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Carod Artal FJ. Clinical management of infectious cerebral vasculitides. Expert Rev Neurother. 2016;16:205–21.

    Article  CAS  PubMed  Google Scholar 

  31. Meya DB, Manabe YC, Boulware DR, Janoff EN. The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum. Curr Opin Infect Dis. 2016;29:10–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Pettersen KD, Pappas PG, Chin-Hong P, Baxi SM. A paradoxical decline: intracranial lesions in two HIV-positive patients recovering from cryptococcal meningitis. BMJ Case Rep. 2015;2015. pii:bcr2015212108.

    Google Scholar 

  33. Post MJ, Thurnher MM, Clifford DB, Nath A, Gonzalez RG, Gupta RK, et al. CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 1: overview and discussion of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome and cryptococcal-immune reconstitution inflammatory syndrome. AJNR Am J Neuroradiol. 2013;34:1297–307.

    Article  CAS  PubMed  Google Scholar 

  34. Jarvis JN, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum JC, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2014;58:736–45.

    Article  PubMed  Google Scholar 

  35. Aye C, Henderson A, Yu H, Norton R. Cryptococcosis-the impact of delay to diagnosis. Clin Microbiol Infect. 2016;22:632–5.

    Article  CAS  PubMed  Google Scholar 

  36. Spampinato C, Leonardi D. Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int. 2013;2013:204237.

    PubMed  PubMed Central  Google Scholar 

  37. Corti M, Solari R, De Carolis L, Cangelosi D, Arechavala A, Negroni R. Candida parapsilosis meningitis in a patient with AIDS. Report of a case and review of the literature. Rev Iberoam Micol. 2013;30:122–4.

    Article  PubMed  Google Scholar 

  38. Colomba C, Trizzino M, Imburgia C, Madonia S, Siracusa L, Giammanco GM. Candida glabrata meningitis and endocarditis: a late severe complication of candidemia. Int J Infect Dis. 2014;29:174–5.

    Article  PubMed  Google Scholar 

  39. Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL. Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. HIV AIDS (Auckl). 2014;6:39–47.

    Google Scholar 

  40. Zhang SC. Cerebral candidiasis in a 4-year-old boy after intestinal surgery. J Child Neurol. 2015;30(3):391.

    Article  PubMed  Google Scholar 

  41. Oeser C, Vergnano S, Naidoo R, Anthony M, Chang J, Chow P, et al. Neonatal invasive fungal infection in England 2004-2010. Clin Microbiol Infect. 2014;20:936–41.

    Article  CAS  PubMed  Google Scholar 

  42. Adams-Chapman I, Bann CM, Das A, Goldberg RN, Stoll BJ, Walsh MC, et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013;163:961–7. e3

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gavino C, Hamel N, Zeng JB, Legault C, Guiot MC, Chankowsky J, et al. Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. J Allergy Clin Immunol. 2016;137:1178–88. e1–7

    Article  CAS  PubMed  Google Scholar 

  44. Gavino C, Cotter A, Lichtenstein D, Lejtenyi D, Fortin C, Legault C, et al. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin Infect Dis. 2014;59:81–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Lanternier F, Mahdaviani SA, Barbati E, Chaussade H, Koumar Y, Levy R, et al. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J Allergy Clin Immunol. 2015;135:1558–68. e2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Herbst M, Gazendam R, Reimnitz D, Sawalle-Belohradsky J, Groll A, Schlegel PG, et al. Chronic Candida albicans meningitis in a 4-year-old girl with a homozygous mutation in the CARD9 gene (Q295X). Pediatr Infect Dis J. 2015;34:999–1002.

    Article  PubMed  Google Scholar 

  47. Wang GH, Dai CL, Liu YF, Li YM. Cerebral and renal abscess and retino-choroiditis secondary to Candida albicans in preterm infants: eight case retrospective study. Clin Exp Obstet Gynecol. 2013;40:519–23.

    CAS  PubMed  Google Scholar 

  48. Lyons JL, Erkkinen MG, Vodopivec I. Cerebrospinal fluid (1,3)-β-D-glucan in isolated candida meningitis. Clin Infect Dis. 2015;60:161–2.

    Article  CAS  PubMed  Google Scholar 

  49. Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA, et al. (1→3)-β-D-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc. 2016;5:277–86.

    Article  PubMed  Google Scholar 

  50. Lin DJ, Sacks A, Shen J, Lee TC. Neurocandidiasis: a case report and consideration of the causes of restricted diffusion. J Radiol Case Rep. 2013;7:1–5.

    PubMed  PubMed Central  Google Scholar 

  51. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291–322.

    Article  PubMed  Google Scholar 

  52. Buddingh EP, Leentjens J, van der Lugt J, Dik WA, Gresnigt MS, Netea MG, et al. interferon-gamma immunotherapy in a patient with refractory disseminated candidiasis. Pediatr Infect Dis J. 2015;34:1391–4.

    Article  PubMed  Google Scholar 

  53. Hayashi S, Maehara T, Mukawa M, Aoyagi M, Yoshino Y, Nemoto S, et al. Successful coil embolization of a ruptured basilar artery aneurysm in a child with leukemia: a case report. Neurol Med Chir (Tokyo). 2014;54:150–4.

    Article  Google Scholar 

  54. Ellenbogen JR, Waqar M, Cooke RP, Javadpour M. Management of granulomatous cerebral aspergillosis in immunocompetent adult patients: a review. Br J Neurosurg. 2016;30:280–5.

    Article  PubMed  Google Scholar 

  55. Mazzaferri F, Adami I, Tocco P, Cazzadori A, Merighi M, Forni A, et al. Thalamo-mesencephalic aspergillus abscess in a heart transplant subject: a case report and literature review. Infez Med. 2015;23:51–5.

    PubMed  Google Scholar 

  56. Segundo JB, da Silva MA, Filho WE, Nascimento AC, Vidal FC, Bezerra GF, et al. Cerebral aspergillosis in a patient with leprosy and diabetes: a case report. BMC Res Notes. 2014;7:689.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Bourne EL, Dimou J. Invasive central nervous system aspergillosis in a patient with Crohn’s disease after treatment with infliximab and corticosteroids. J Clin Neurosci. 2016;30:163–4.

    Article  PubMed  Google Scholar 

  58. Saghrouni F, Ben Youssef Y, Gheith S, Bouabid Z, Ben Abdeljelil J, Khammari I, et al. Twenty-nine cases of invasive aspergillosis in neutropenic patients. Med Mal Infect. 2011;41:657–62.

    Article  CAS  PubMed  Google Scholar 

  59. Kourkoumpetis TK, Desalermos A, Muhammed M, Mylonakis E. Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore). 2012;91:328–36.

    Article  Google Scholar 

  60. Shamim MS, Enam SA, Ali R, Anwar S. Craniocerebral aspergillosis: a review of advances in diagnosis and management. J Pak Med Assoc. 2010;60:573–9.

    PubMed  Google Scholar 

  61. Naik V, Ahmed FU, Gupta A, Garg A, Sarkar C, Sharma B, et al. Intracranial fungal granulomas: a single institutional clinicopathologic study of 66 patients and review of the literature. World Neurosurg. 2015;83:1166–72.

    Article  PubMed  Google Scholar 

  62. Yuan L, Prayson RA. Optic nerve aspergillosis. J Clin Neurosci. 2015;22:1191–3.

    Article  PubMed  Google Scholar 

  63. Ouyang T, Zhang N, Wang L, Jiao J, Zhao Y, Li Z, et al. Primary Aspergillus sellar abscess simulating pituitary tumor in immunocompetent patient. J Craniofac Surg. 2015;26:e86–8.

    Article  PubMed  Google Scholar 

  64. Shinya Y, Miyawaki S, Nakatomi H, Okano A, Imai H, Shin M, et al. Recurrent cerebral aneurysm formation and rupture within a short period due to invasive aspergillosis of the nasal sinus; pathological analysis of the catastrophic clinical course. Int J Clin Exp Pathol. 2015;8:13510–22.

    PubMed  PubMed Central  Google Scholar 

  65. Okazaki T, Shiraishi S, Iwasa N, Kitamura E, Mizutani T, Hanada Y, et al. Extended voriconazole therapy and long term survival of a patient with invasive central aspergillosis causing stroke. Rinsho Shinkeigaku. 2015;55:472–7.

    Article  PubMed  Google Scholar 

  66. McCaslin AF, Lall RR, Wong AP, Lall RR, Sugrue PA, Koski TR. Thoracic spinal cord intramedullary aspergillus invasion and abscess. J Clin Neurosci. 2015;22:404–6.

    Article  PubMed  Google Scholar 

  67. Morgand M, Rammaert B, Poirée S, Bougnoux ME, Tran H, Kania R, et al. Chronic invasive aspergillus sinusitis and otitis with meningeal extension successfully treated with voriconazole. Antimicrob Agents Chemother. 2015;59:7857–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Forest F, Cinotti E, Habougit C, Ginguéné C, Perrot JL, Labeille B, et al. Rapid characterization of human brain aspergillosis by confocal microscopy on a thick squash preparation. Cytopathology. 2016;27:221–2.

    Article  CAS  PubMed  Google Scholar 

  69. Wang RX, Zhang JT, Chen Y, Huang XS, Jia WQ, Yu SY. Cerebral aspergillosis: a retrospective analysis of eight cases. Int J Neurosci. 2017;127:339–43.

    Article  CAS  PubMed  Google Scholar 

  70. Gabelmann A, Klein S, Kern W, Krüger S, Brambs HJ, Rieber-Brambs A, et al. Relevant imaging findings of cerebral aspergillosis on MRI: a retrospective case-based study in immunocompromised patients. Eur J Neurol. 2007;14:548–55.

    Article  CAS  PubMed  Google Scholar 

  71. Malani AN, Kerr LE, Kauffman CA. Voriconazole: how to use this antifungal agent and what to expect. Semin Respir Crit Care Med. 2015;36:786–95.

    Article  PubMed  Google Scholar 

  72. Conant MM, Sha BE, Proia LA. Use of posaconazole delayed-release tablets for treatment of invasive aspergillosis. Mycoses. 2015;58:313–4.

    Article  PubMed  Google Scholar 

  73. Ellenbogen JR, Waqar M, Denning DW, Cooke RP, Skinner DW, Lesser T, et al. Posaconazole responsive cerebral aspergillosis in an immunocompetent adult. J Clin Neurosci. 2014;21:1825–7.

    Article  PubMed  Google Scholar 

  74. Ogawa T, Matsumoto K, Tsujimoto K, Hishiya N, Yamada Y, Uno K, et al. Chronic invasive sinus and intracerebral aspergillosis controlled by combination therapy with micafungin and a daily dose of 400 mg itraconazole oral solution. J Infect Chemother. 2015;21:134–7.

    Article  CAS  PubMed  Google Scholar 

  75. Panackal AA, Bennett JE, Williamson PR. Treatment options in invasive aspergillosis. Curr Treat Options Infect Dis. 2014;6:309–25.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011;39:201–10.

    Article  CAS  PubMed  Google Scholar 

  77. Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Brüggemann RJ, Chowdhary A, et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat. 2015;21-22:30–40.

    Article  PubMed  Google Scholar 

  78. Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012;54(suppl 1):S8–S15.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Vehreschild JJ, Birtel A, Vehreschild MJ, Liss B, Farowski F, Kochanek M, et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol. 2013;39:310–24.

    Article  CAS  PubMed  Google Scholar 

  80. Higo T, Kobayashi T, Yamazaki S, Ando S, Gonoi W, Ishida M, et al. Cerebral embolism through hematogenous dissemination of pulmonary mucormycosis complicating relapsed leukemia. Int J Clin Exp Pathol. 2015;8:13639–42.

    PubMed  PubMed Central  Google Scholar 

  81. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(suppl 1):S23–34.

    Article  PubMed  Google Scholar 

  82. McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ. Mold infections of the central nervous system. N Engl J Med. 2014;371:150–60.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  83. Jiang N, Zhao G, Yang S, Lin J, Hu L, Che C, et al. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially. BMC Ophthalmol. 2016;16:10.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Katsantonis NG, Hunter JB, O’Connell BP, He J, Lewis JS Jr, Wanna GB. Temporal bone mucormycosis. Ann Otol Rhinol Laryngol. 2016;125:850–3.

    Article  PubMed  Google Scholar 

  85. Stretz C, Mook A, Modak JM, Rodriguez JM, Nouh AM. Gerstmann Syndrome in a patient with aggressive mucormycosis. Neurohospitalist. 2017;7:102–3.

    Article  PubMed  Google Scholar 

  86. Mulki R, Masab M, Eiger G, Perloff S. Lethargy and vision loss: successful management of rhinocerebral mucormycosis. BMJ Case Rep. 2016;2016. pii:bcr2016215855.

    Google Scholar 

  87. Ermak D, Kanekar S, Specht CS, Wojnar M, Lowden M. Looks like a stroke, acts like a stroke, but it’s more than a stroke: a case of cerebral mucormycosis. J Stroke Cerebrovasc Dis. 2014;23:e403–4.

    Article  PubMed  Google Scholar 

  88. Benachinmardi KK, Rajalakshmi P, Veenakumari HB, Bharath RD, Vikas V, Mahadevan A, et al. Successful treatment of primary cerebral mucormycosis: Role of microbiologist. Indian J Med Microbiol. 2016;34:550–3.

    Article  CAS  PubMed  Google Scholar 

  89. Ville S, Talarmin JP, Gaultier-Lintia A, Bouquié R, Sagan C, Le Pape P, et al. Disseminated mucormycosis with cerebral involvement owing to Rhizopus microsporus in a kidney recipient treated with combined liposomal amphotericin B and posaconazole therapy. Exp Clin Transplant. 2016;14:96–9.

    PubMed  Google Scholar 

  90. Peixoto D, Gagne LS, Hammond SP, Gilmore ET, Joyce AC, Soiffer RJ, et al. Isavuconazole treatment of a patient with disseminated mucormycosis. J Clin Microbiol. 2014;52:1016–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Wheat LJ, Azar MM, Bahr NC, Spec A, Relich RF, Hage C. Histoplasmosis. Infect Dis Clin N Am. 2016;30:207–27.

    Article  Google Scholar 

  92. Schuster JE, Wushensky CA, Di Pentima MC. Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations. Pediatr Infect Dis J. 2013;32:794–6.

    Article  PubMed  Google Scholar 

  93. Nyalakonda H, Albuerne M, Suazo Hernandez LP, Sarria JC. Central nervous system histoplasmosis in acquired immunodeficiency syndrome. Am J Med Sci. 2016;351:177–86.

    Article  PubMed  Google Scholar 

  94. Osorio N, López Y, Jaramillo JC. Histoplasmosis of the central nervous system in an immunocompetent patient. Biomedica. 2014;34:506–13.

    Article  PubMed  Google Scholar 

  95. López LF, Valencia Y, Tobón ÁM, Velásquez O, Santa CD, Cáceres DH, et al. Childhood histoplasmosis in Colombia: Clinical and laboratory observations of 45 patients. Med Mycol. 2016;54:677–83.

    Article  PubMed  Google Scholar 

  96. Schulze AB, Heptner B, Kessler T, Baumgarten B, Stoica V, Mohr M, et al. Progressive histoplasmosis with hemophagocytic lymphohistiocytosis and epithelioid cell granulomatosis: a case report and review of the literature. Eur J Haematol. 2017;99:91–100. https://doi.org/10.1111/ejh.12886. [Epub ahead of print]

    Article  PubMed  Google Scholar 

  97. Carod-Artal F, Venturini M, Gomes E, de Mello M. Chronic central nervous system histoplasmosis in an immunocompetent patient. Neurologia. 2008;23:263–8.

    CAS  PubMed  Google Scholar 

  98. Nguyen FN, Kar JK, Zakaria A, Schiess MC. Isolated central nervous system histoplasmosis presenting with ischemic pontine stroke and meningitis in an immune-competent patient. JAMA Neurol. 2013;70:638–41.

    Article  PubMed  Google Scholar 

  99. Andrade AI, Donato M, Previgliano C, Hardjasudarma M. Histoplasmosis brain abscesses in an immunocompetent adult. A case report and literature review. Neuroradiol J. 2014;27:334–8.

    Article  PubMed  Google Scholar 

  100. Loughan AR, Perna R, Hertza J. Cognitive impairment and memory loss associated with histoplasmosis: a case study. Clin Neuropsychol. 2014;28:514–24.

    Article  PubMed  Google Scholar 

  101. Estrada-Bellmann I, Camara-Lemarroy CR, Flores-Cantu H, Calderon-Hernandez HJ, Villareal-Velazquez HJ. Hemichorea in a patient with HIV-associated central nervous system histoplasmosis. Int J STD AIDS. 2016;27:75–7.

    Article  CAS  PubMed  Google Scholar 

  102. Veeravagu A, Ludwig C, Camara-Quintana JQ, Jiang B, Lad N, Shuer L. Fungal infection of a ventriculoperitoneal shunt: histoplasmosis diagnosis and treatment. World Neurosurg. 2013;80:222.e5–13.

    Google Scholar 

  103. Starkey J, Moritani T, Kirby P. MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217–30.

    Article  CAS  PubMed  Google Scholar 

  104. Myint T, Anderson AM, Sanchez A, Farabi A, Hage C, Baddley JW, et al. Histoplasmosis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore). 2014;93:11–8.

    Article  CAS  Google Scholar 

  105. Tan LA, Kasliwal MK, Nag S, O’Toole JE, Traynelis VC. Rapidly progressive quadriparesis heralding disseminated coccidioidomycosis in an immunocompetent patient. J Clin Neurosci. 2014;21:1049–51.

    Article  PubMed  Google Scholar 

  106. Stevens DA, Zhang Y, Finkelman MA, Pappagianis D, Clemons KV, Martinez M. Cerebrospinal Fluid (1,3)-beta-d-glucan testing is useful in diagnosis of coccidioidal meningitis. J Clin Microbiol. 2016;54:2707–10.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Bamberger DM, Pepito BS, Proia LA, Ostrosky-Zeichner L, Ashraf M, Marty F, et al. Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis. Mycoses. 2015;58:598–602.

    Article  PubMed  Google Scholar 

  108. Nelson S, Vytopil M. Recurrence of coccidioidal meningitis after discontinuation of fluconazole. JAMA Neurol. 2013;70:1586.

    Article  PubMed  Google Scholar 

  109. Bellissimo-Rodrigues F, Bollela VR, Da Fonseca BA, Martinez R. Endemic paracoccidioidomycosis: relationship between clinical presentation and patients’ demographic features. Med Mycol. 2013;51:313–8.

    Article  PubMed  Google Scholar 

  110. Pedroso VS, Lyon AC, Araújo SA, Veloso JM, Pedroso ER, Teixeira AL. Paracoccidioidomycosis case series with and without central nervous system involvement. Rev Soc Bras Med Trop. 2012;45:586–90.

    Article  PubMed  Google Scholar 

  111. Silva-Vergara ML, Rocha IH, Vasconcelos RR, Maltos AL, Neves Fde F, Teixeira Lde A, et al. Central nervous system paracoccidioidomycosis in an AIDS patient: case report. Mycopathologia. 2014;177:137–41.

    Article  PubMed  Google Scholar 

  112. Abud LG, Queiroz RM, Abud TG. Concomitant pulmonary and central nervous system paracoccidioidomycosis with cerebellar abscess. Rev Soc Bras Med Trop. 2015;48:789.

    Article  PubMed  Google Scholar 

  113. Souza PV, Pinto WB, Matas SL. Paracoccidioidomycosis: a rare cause of infectious encephalomyelopathy. Arq Neuropsiquiatr. 2014;72:904–5.

    Article  PubMed  Google Scholar 

  114. Reis F, Collier PP, Souza TF, Lopes GP, Bronzatto E, Silva Junior NA, et al. Neuroparacoccidioidomycosis (NPCM): magnetic resonance imaging (MRI) findings. Mycopathologia. 2013;175:181–6.

    Article  PubMed  Google Scholar 

  115. Shikanai-Yasuda MA. Paracoccidioidomycosis treatment. Rev Inst Med Trop Sao Paulo. 2015;57(Suppl 19):31–7.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Codifava M, Guerra A, Rossi G, Paolucci P, Iughetti L. Unusual osseous presentation of blastomycosis in an immigrant child: a challenge for European pediatricians. Ital J Pediatr. 2012;38:69.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Bush JW, Wuerz T, Embil JM, Del Bigio MR, McDonald PJ, Krawitz S. Outcomes of persons with blastomycosis involving the central nervous system. Diagn Microbiol Infect Dis. 2013;76:175–81.

    Article  PubMed  Google Scholar 

  118. Munich SA, Johnson AK, Ahuja SK, Venizelos A, Byrne RW. Large cerebellar mass lesion: A rare intracranial manifestation of blastomycosis. Surg Neurol Int. 2013;4:141.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Akture E, Salamat S, Baskaya MK. Intracranial blastomycosis presenting as an enhancing cerebellopontine mass. Turk Neurosurg. 2013;23:252–5.

    PubMed  Google Scholar 

  120. Chiller TM, Roy M, Nguyen D, Guh A, Malani AN, Latham R, et al. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med. 2013;369:1610–9.

    Article  CAS  PubMed  Google Scholar 

  121. Didehdar M, Gokanian A, Sofian M, Mohammadi S, Mohammadi R, Aslani N, et al. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA. J Mycol Med. 2015;25:81–6.

    Article  CAS  PubMed  Google Scholar 

  122. Deng S, Pan W, Liao W, de Hoog GS, Gerrits van den Ende AH, Vitale RG, et al. Combination of amphotericin b and flucytosine against neurotropic species of melanized fungi causing primary cerebral phaeohyphomycosis. Antimicrob Agents Chemother. 2016;60:2346–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Pappas PG. Lessons learned in the multistate fungal infection outbreak in the United States. Curr Opin Infect Dis. 2013;26:545–50.

    Article  CAS  PubMed  Google Scholar 

  124. Kantarcioglu AS, Guarro J, De Hoog S, Apaydin H, Kiraz N. An updated comprehensive systematic review of Cladophialophora bantiana and analysis of epidemiology, clinical characteristics, and outcome of cerebral cases. Med Mycol. 2016;55:579–604.

    Google Scholar 

  125. Shimogawa T, Sayama T, Haga S, Akiyama T, Makihara K, Morioka T. Brain abscess due to infection with dematiaceous fungi Cladophialophora bantiana associated with hypogammaglobulinemia following gastrectomy: A Case Report. No Shinkei Geka. 2016;44:59–66.

    PubMed  Google Scholar 

  126. Mansour A, Jordan K. Disseminated Cladophialophora bantiana disease in a patient with prediabetes. BMJ Case Rep. 2014;2014. pii:bcr2014206426.

    Google Scholar 

  127. Kantarcioglu AS, Guarro J, de Hoog GS, Apaydin H, Kiraz N, Balkan II, et al. A case of central nervous system infection due to Cladophialophora bantiana. Rev Iberoam Micol. 2016;33:237–41.

    Article  PubMed  Google Scholar 

  128. Brokalaki EI, Sommerwerck U, von Heinegg EH, Hillen U. Ochroconis gallopavum infection in a lung transplant recipient: report of a case. Transplant Proc. 2012;44:2778–80.

    Article  CAS  PubMed  Google Scholar 

  129. Cardeau-Desangles I, Fabre A, Cointault O, Guitard J, Esposito L, Iriart X, et al. Disseminated Ochroconis gallopava infection in a heart transplant patient. Transpl Infect Dis. 2013;15:E115–8.

    Article  CAS  PubMed  Google Scholar 

  130. Chen TC, Ho MW, Chien WC, Lin HH. Disseminated Scedosporium apiospermum infection in a near-drowning patient. J Formos Med Assoc. 2016;115:213–4.

    Article  PubMed  Google Scholar 

  131. Slone HW, Kontzialis M, Kiani B, Triola C, Oettel DJ, Bourekas EC. MRI with magnetic resonance spectroscopy of multiple brain abscesses secondary to Scedosporium apiospermum in two immunocompromised patients. Clin Imaging. 2013;37:361–6.

    Article  PubMed  Google Scholar 

  132. Husain N, Chen TC, Hou JK. An unusual cause of diarrhea in an immunocompromised patient. Scedosporium apiospermum colitis and brain abscess. Gastroenterology. 2013;145(519):697–8.

    Google Scholar 

  133. Lin D, Kamili Q, Lai S, Musher DM, Hamill R. Cerebral Scedosporium apiospermum infection presenting with intestinal manifestations. Infection. 2013;41:723–6.

    Article  CAS  PubMed  Google Scholar 

  134. Nakamura Y, Suzuki N, Nakajima Y, Utsumi Y, Murata O, Nagashima H, et al. Scedosporium aurantiacum brain abscess after near-drowning in a survivor of a tsunami in Japan. Respir Investig. 2013;51:207–11.

    Article  PubMed  Google Scholar 

  135. Carod-Artal FJ, Ferreira-Coral L, Mauro-Couto J, Gomes E. de Agassiz-Vasques M. Chronic spinal epidural abscess caused by Scedosporium prolificans in an immunocompetent patient. Spine (Phila Pa 1976). 2009;34:E330–2.

    Article  Google Scholar 

  136. Garcia RR, Min Z, Narasimhan S, Bhanot N. Fusarium brain abscess: case report and literature review. Mycoses. 2015;58:22–6.

    Article  PubMed  Google Scholar 

  137. Durán Graeff L, Seidel D, Vehreschild MJ, Hamprecht A, Kindo A, Racil Z, et al. Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses. 2017;60:273–9.

    Article  PubMed  CAS  Google Scholar 

  138. Haidar G, Zerbe CS, Cheng M, Zelazny AM, Holland SM, Sheridan KR. Phellinus species: An emerging cause of refractory fungal infections in patients with X-linked chronic granulomatous disease. Mycoses. 2017;60:155–60.

    Article  CAS  PubMed  Google Scholar 

  139. Frank T, Esquenazi Y, Nigo M, Wanger A, Portnoy B, Shepard S. Disseminated phaeohyphomycosis with brain abscess and biliary invasion due to Bipolaris spp. in an immunocompetent patient. Ann Clin Lab Sci. 2016;46:439–42.

    PubMed  Google Scholar 

  140. Freitas DF, Lima MA. de Almeida-Paes R, Lamas CC, do Valle AC, Oliveira MM, et al. Sporotrichosis in the central nervous system caused by Sporothrix brasiliensis. Clin Infect Dis. 2015;61:663–4.

    Article  PubMed  Google Scholar 

  141. Moreira JA, Freitas DF, Lamas CC. The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection. 2015;43:267–76.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Sciences and Medicine Faculty, Universitat Internacional de Catalunya (UIC), Barcelona, Spain

    Francisco Javier Carod-Artal M.D., Ph.D.

  2. Department of Neurology, Raigmore Hospital, Old Perth Road, Inverness, IV2 3UJ, Highlands, UK

    Francisco Javier Carod-Artal M.D., Ph.D.

Authors
  1. Francisco Javier Carod-Artal M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francisco Javier Carod-Artal M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Neurology, Hospital de Galdakao-Usansolo, Galdacano, Vizcaya, Spain

    Juan Carlos García-Moncó

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Carod-Artal, F.J. (2018). Fungal Infections of the Central Nervous System. In: García-Moncó, J. (eds) CNS Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-70296-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70296-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70295-7

  • Online ISBN: 978-3-319-70296-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation